FourThought Financial’s Enzo Biochem, Inc. ENZ Stock Holding History

FourThought Financial’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$0	Hold	217	–	–	﹤0.01%	1583
2022 Q2	$0	Hold	217	–	–	﹤0.01%	1574
2022 Q1	$1K	Hold	217	–	–	﹤0.01%	1440
2021 Q4	$1K	Hold	217	–	–	﹤0.01%	1474
2021 Q3	$1K	Hold	217	–	–	﹤0.01%	1533
2021 Q2	$1K	Hold	217	–	–	﹤0.01%	1509
2021 Q1	$1K	Buy	217 +20	+10%	+$62	﹤0.01%	1480
2020 Q4	$1K	Buy	+197	New	+$429	﹤0.01%	1474

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FourThought Financial's ENZ Position: Q3 2022 in Review

FourThought Financial held its Enzo Biochem, Inc. (ENZ) position steady in Q3 2022 at 217 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1583.

FourThought Financial first reported a position in ENZ in Q4 2020 and has held it in 8 quarters since. The position peaked at $1K in Q1 2022. 49 funds tracked by Wall St. Rank hold ENZ as of Q3 2022.

FourThought Financial held 217 shares of Enzo Biochem, Inc. worth $0 as of Q3 2022.
FourThought Financial left its Enzo Biochem, Inc. share count unchanged in Q3 2022.
Enzo Biochem, Inc. made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #1583 holding.
FourThought Financial first reported a position in Enzo Biochem, Inc. in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's Enzo Biochem, Inc. position peaked at $1K in Q1 2022.
49 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.